Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 29, 2026 | $5.73 | +27.1% | $40.87B | +26.2% | $7.26 |
| Q1 FY26ended Mar 31, 2026 | Apr 29, 2026 | $9.83 | −4.6% | $39.65B | +23.5% | $10.20 |
| Q4 FY25ended Dec 31, 2025 | — | −$6.58 | — | $32.38B | +12.0% | — |
| Q3 FY25ended Sep 30, 2025 | — | $1.62 | −59.3% | $32.25B | +11.0% | — |
| Q2 FY25ended Jun 30, 2025 | — | $4.51 | −19.8% | $32.39B | +9.6% | — |
| Q1 FY25ended Mar 31, 2025 | — | $10.30 | +68.6% | $32.11B | +8.4% | — |
| Q4 FY24ended Dec 31, 2024 | — | −$5.74 | — | $28.92B | +10.5% | — |
| Q3 FY24ended Sep 30, 2024 | — | $3.98 | −40.7% | $29.05B | +11.3% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Humana shares, not any token. As of Jul 29, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $5.62 | — | $29.54B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $6.11 | — | $29.61B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | −$4.39 | — | $26.17B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $6.71 | — | $26.12B | — | — |